Search

Primary Outcome Measure: Maximum tolerated dose of nivolumab [Time Frame: 56 days] Will be defined as the starting dose level at which 1/6 subjects experience dose limiting toxicity (DLT) with the next higher dose having at least >= 2 participants encountering DLT. Toxicity data will be…

Have at least 20 nodules of approximately 0.5 to 2 cm. The nodules must be pruritic and present on at least 2 different anatomical locations (not be localized), involve the extremities, with extensor extremity involvement greater than the flexor extremity involvement. Nodules on the head (face and…

Primary Outcome Measures: Rate of Progression to Prostate Cancer (PCa) [Time Frame: 24 months] Number of participants with clinical progression defined as a composite outcome on repeat prostate biopsy >33% of biopsy cores positive for cancer or >50% of any biopsy tissue core positive for…

Babak Sarani, MD, FACS, FCCM is the Founder and Chief of the Center for Trauma and Critical Care at GW Hospital and the Virginia Hospital Center and a Professor of Surgery and Emergency Medicine at the GW University School of Medicine & Health Sciences. He is currently the Chair of the American…

Pablo Serrano Rodriguez, MD, FACS, is an assistant professor of surgery and surgical director of the pancreas transplant program. He specializes in abdominal organ transplantation, hepatobiliary surgery, and minimally invasive and robotic surgery. Dr. Serrano is originally from Mexico and received…